UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

The importance of fertility preservation in women with early breast cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20663-e20663

2009

Volltextzugriff (PDF)

Retrospective analysis of the effect on overall survival of radiotherapy and chemotherapy sequence as treatment for primary breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1127-1127

2011

Volltextzugriff (PDF)

Are St. Gallen endocrine response classes predictive for recurrence rates over time?

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.576-576

2011

Volltextzugriff (PDF)

Genomic patterns resembling BRCA-mutated breast cancers and benefit of intensified carboplatin-based chemotherapy in HER2-negative breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10505-10505

2011

Volltextzugriff (PDF)

T-cell lymphoblastic lymphoma in children and adolescents: The experience of the Israel Society of Pediatric Hematology Oncology

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.9574-9574

2010

Volltextzugriff (PDF)

Effect of screening on the detection of good and poor prognosis breast cancers

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1520-1520

2010

Volltextzugriff (PDF)

Outcome prediction by the 70-gene profile in the context of the National Comprehensive Cancer Network (NCCN) guidelines

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.535-535

2009

Volltextzugriff (PDF)

Early determination of metastatic potential in breast cancer: The 70-gene signature in small tumors

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.518-518

2009

Volltextzugriff (PDF)

Selective benefit of high-dose, platinum-containing, alkylating chemotherapy with stem cell rescue for patients with breast cancers with an expansive growth pattern on histology

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.587-587

2009

Volltextzugriff (PDF)

Evaluation of the effect of screening on the detection of good and poor prognosis breast cancers

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.1525-1525

2009

Volltextzugriff (PDF)

The 70-gene profile and chemotherapy benefit in 1,600 breast cancer patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.512-512

2009

Volltextzugriff (PDF)

Ligands of EGFR and the insulin-like growth factor family as serum biomarkers for response to EGFR-inhibitors in patients with advanced NSCLC

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8100-8100

2009

Volltextzugriff (PDF)

Homologous recombination defects in sporadic breast cancers

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.22102-22102

2008

Volltextzugriff (PDF)

Implementation assessment of the 70-gene prognosis signature for breast cancer diagnostics

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6575-6575

2008

Volltextzugriff (PDF)

Phosphorylation of the estrogen receptor α at serine 305 and prediction of tamoxifen resistance in breast cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.11058-11058

2008

Volltextzugriff (PDF)

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

Journal of clinical oncology, 2022-07, Vol.40 (21), p.JCO2101536-2374

2022

Volltextzugriff (PDF)

Challenges in the Use of DNA Repair Deficiency As a Biomarker in Breast Cancer

Journal of clinical oncology, 2015-06, Vol.33 (17), p.1867-1869

2015

Volltextzugriff (PDF)

Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort Study

Journal of clinical oncology, 2017-08, Vol.35 (24), p.2814-2819

2017

Volltextzugriff (PDF)

Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial

Journal of clinical oncology, 2022-09, Vol.40 (25), p.JCO2100311-2945

2022

Volltextzugriff (PDF)

Immune landscape of breast tumors with low and intermediate estrogen receptor (ER) expression

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.566-566

2022

Volltextzugriff (PDF)

Molecular profiling is rather likely to be cost effective

Journal of clinical oncology, 2015-05, Vol.33 (14), p.1626-1627

2015

Volltextzugriff (PDF)

Predictive value of ectopic HORMAD1 tumor expression for high-dose platinum-based chemotherapy benefit in patients with high-risk HER2-negative breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.541-541

2022

Volltextzugriff (PDF)

Treatment and outcome of patients with high-grade advanced ovarian cancer (AOC): Real-world data in Germany (QS Ovar of the AGO Study Group)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17613-e17613

2022

Volltextzugriff (PDF)

High dose alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Results from the randomized phase 3 OLIGO study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1097-1097

2023

Volltextzugriff (PDF)

Angiotensinogen gene silencing to predict bevacizumab response in recurrent glioblastoma patients

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2027-2027

2018

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

PublikationsformBerichte

ThemaBiological And Medical Sciences

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(71)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The importance of fertility preservation in women with early breast cancer

Retrospective analysis of the effect on overall survival of radiotherapy and chemotherapy sequence as treatment for primary breast cancer

Are St. Gallen endocrine response classes predictive for recurrence rates over time?

Genomic patterns resembling BRCA-mutated breast cancers and benefit of intensified carboplatin-based chemotherapy in HER2-negative breast cancer

T-cell lymphoblastic lymphoma in children and adolescents: The experience of the Israel Society of Pediatric Hematology Oncology

Effect of screening on the detection of good and poor prognosis breast cancers

Outcome prediction by the 70-gene profile in the context of the National Comprehensive Cancer Network (NCCN) guidelines

Early determination of metastatic potential in breast cancer: The 70-gene signature in small tumors

Selective benefit of high-dose, platinum-containing, alkylating chemotherapy with stem cell rescue for patients with breast cancers with an expansive growth pattern on histology

Evaluation of the effect of screening on the detection of good and poor prognosis breast cancers

The 70-gene profile and chemotherapy benefit in 1,600 breast cancer patients

Ligands of EGFR and the insulin-like growth factor family as serum biomarkers for response to EGFR-inhibitors in patients with advanced NSCLC

Homologous recombination defects in sporadic breast cancers

Implementation assessment of the 70-gene prognosis signature for breast cancer diagnostics

Phosphorylation of the estrogen receptor α at serine 305 and prediction of tamoxifen resistance in breast cancer

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

Challenges in the Use of DNA Repair Deficiency As a Biomarker in Breast Cancer

Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort Study

Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial

Immune landscape of breast tumors with low and intermediate estrogen receptor (ER) expression

Molecular profiling is rather likely to be cost effective

Predictive value of ectopic HORMAD1 tumor expression for high-dose platinum-based chemotherapy benefit in patients with high-risk HER2-negative breast cancer

Treatment and outcome of patients with high-grade advanced ovarian cancer (AOC): Real-world data in Germany (QS Ovar of the AGO Study Group)

High dose alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Results from the randomized phase 3 OLIGO study

Angiotensinogen gene silencing to predict bevacizumab response in recurrent glioblastoma patients

Aktive Filter

Suchergebnisse filtern